Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

Jobst C. von Einem(Ludwig-Maximilians-Universität München), Dominik Paul Modest, Sebastian Stintzing(University of Southern California), Volker Heinemann(Comprehensive Cancer Center Vienna), Thomas Decker, Michael Haas(Ensemble Therapeutics (United States)), Stefan Boeck(Ludwig-Maximilians-Universität München), Philipp Aubele(Institut für Urheber- und Medienrecht), Julian Walter Holch(Ludwig-Maximilians-Universität München), Martina Stauch, Ursula Vehling‐Kaiser(University of Applied Sciences Landshut), Swantje Held(ClinAssess (Germany)), Andreas Jung(German Cancer Research Center), Marlies Michl(LMU Klinikum), Clemens Gießen, Stefan Klein(Praxis für Hämatologie und Onkologie), Ludwig Fischer von Weikersthal(Klinikum St. Marien Amberg), Thomas Kirchner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christoph Schulz, Holger G. Hass(Paracelsus-Kliniken)
Journal of Cancer Research and Clinical Oncology
May 9, 2014
10.1007/s00432-014-1678-3
Cited by 112

Related Papers

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
|The Lancet|2019|2.6k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer
|JAMA Oncology|2016|722
β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
|American Journal Of Pathology|1999|663
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
|European Journal of Cancer|2016|533